Clinical Applications
Precision-GI™ has been used in over 400 EUS-guided biopsy procedures performed at leading international endoscopy centers and has been validated in multiple clinical trials.
01
Pancreatic Masses
02
Liver Biopsy
03
Lung Cancer
Pipeline
Pancreatic Masses
Pancreatic masses require a definitive diagnosis to begin patients’ treatment journey, yet obtaining a timely and accurate diagnosis can be challenging.
Precision-GI™ represents a differentiated, innovative approach to EUS‑guided tissue acquisition. Our platform supports patients and clinicians with:
Precision-GI™ needle passage
Pancreatic parenchyma
Fig. 1 Precision-GI™ needle passage through the pancreatic parenchyma.
01
A motorized, precision cutting mechanism designed for controlled tissue acquisition of often times fibrotic pancreatic masses under EUS guidance.
02
A super-elastic needle engineered for optimal access to challenging anatomic configurations, including the uncinate process, while ensuring no needle deformation.
03
An industry leading ergonomic handle, designed to optimize physician procedural comfort and efficiency while reducing reliance on repeated manual needle actuations used with conventional needles.
4.6/5
superior histology scores
Together, these advantages translate into non fragmented, high-quality cores. Studies have demonstrated superior histology scores (4.6/5) and enhanced adequacy for histopathology analysis and genomic profiling.*
Fig. 2 Histology of the pancreatic tumor (orig. mag. ×40).
Fig. 3 Pancreatic head core sample in one pass. Rosario Ligresti, MD, FASGE, Case report
*Dornblaser DW, Khamaysi I, Gross SA. iGIE. 2023;2(2):126-130.
**Fig 1 & Fig 2 Source: Application of a novel endoscopic ultrasound–guided motorized fine needle for liver and pancreatic lesion biopsy - VideoGIE
Liver Biopsy
Reduced number of actuations with Precision-GI™ may minimize potential trauma to the liver, supporting consistent, high‑quality tissue acquisition.
Precision-GI™
Standard manual FNB
Fig.1 Liver Biopsy Specimen Comparison. Courtesy of Carlos Robles-Medranda, MD; Head of Endoscopy Services at the IECED Medical Center
Endoscopic ultrasound-guided liver biopsy (EUS-LB) is increasingly recognized as an attractive alternative to conventional percutaneous (PC) or transjugular (TJ) approaches, offering a minimally invasive, high-diagnostic-yield solution that enables endohepatologists to provide a “one stop shop” solution for patients with confirmed or suspected liver disease in need of liver biopsy.*
* Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis
Fig. 2 Liver biopsy case with Precision-GI™. Courtesy of Grace Kim, MD, Chicago Live Event 2026
Pipeline – Lung Cancer
Lung cancer is considered a leading global indication for molecular and biologic drug advanced therapies, in which diagnostic sample quality and advanced navigation systems play a critical role in guiding treatment strategies*
Endoscopic Ultrasound (EBUS): minimally invasive access to critical central thoracic targets
Comprehensive NGS and next‑generation lung navigation systems
Pipeline application
Disclaimer: [text to be provided by Limaca]
Advanced procedures like Endoscopic Ultrasound (EBUS) enable minimally invasive access to critical central thoracic targets without requiring major surgery.
As clinical demand shifts toward comprehensive NGS and next‑generation lung navigation systems, Integrating Precision-GI™, Next-Gen motorized biopsy device, with these advanced systems will support significant progress in providing accurate diagnostic for these patients leading to more efficient treatment.
* The progress of biomarkers detection to lung cancer. Discover Oncology. Springer Nature. 2026;17:519.